Portfolio

Portfolio and platform companies

WBV works with a focused group of biotech therapeutics and biotech infrastructure companies aligned with our venture creation and investment strategy.

Selected Companies

Therapeutics and infrastructure platforms aligned with venture creation.

WBV focuses on opportunities where scientific differentiation, structured execution, strategic positioning, and aligned capital formation can work together to create durable biotech value.

Portfolio Company

Protirna Therapeutics

Protirna Therapeutics is an early-stage biotech therapeutics company developing novel approaches around dark genome-derived biology, target discovery, and immunotherapy opportunities.

Visit Website

Portfolio Company

Adirna Therapeutics

Adirna Therapeutics is an emerging biotech therapeutics company focused on RNA-driven innovation and differentiated therapeutic opportunities.

Learn More

Portfolio Company

VentriLinks

VentriLinks is an AI-powered infrastructure platform for biotech fundraising, partnering, IP commercialization, opportunity intelligence, and opportunity activation. WBV works closely with VentriLinks to identify and activate selected venture creation, incubation, acceleration, and investment opportunities.

Visit VentriLinks

Platform Alignment

Venture creation, intelligence, and investment integrated into one execution layer.

WBV is designed to operate as a selective biotech therapeutics venture platform — combining opportunity intelligence, activation pathways, strategic capital, and coordinated execution across aligned partner networks.

Selective venture creation and investment for differentiated biotech opportunities.

WBV works selectively with therapeutics and infrastructure companies aligned with our venture-building and investment model.